Teglicar [CAS 250694-07-6]

Teglicar is a selective and reversible orally active liver isoform of carnitine palmitoyl-transferase 1 (L-CPT1) inhibitor with an IC50 value of 0.68 μM and a Ki value of 0.36 μM. Teglicar has a potential antihyperglycemic propert. Teglicar can be used for the research of diabetes and neurodegenerative disease including Huntington's disease (HD) [1][2].

[250694-07-6]

C22H45N3O3

399.61

O=C(N[C@H](CC([O-])=O)C[N+](C)(C)C)NCCCCCCCCCCCCCC

Endogenous Metabolite

98

DMSO : 19 mg/mL (ultrasonic) |Ethanol : 100 mg/mL (ultrasonic; heat to 60°C) |H2O : 10 mg/mL (ultrasonic)

-20°C, 3 years; 4°C, 2 years (Powder)

Room Temperature